Table 2.

Examples of Studies Reporting Adult Height in Girls Treated With a GnRHa for CPP

First Author	Year of Publication	No. of Girls Participating	Modality Used and Duration of GnRH Treatmenta	Adult Height Achieved, Mean ± SD (cm)	Height Increase Above Predicted at Baseline (cm)
Heger [24]	1999	50	Depot triptorelin 4.4 ± 2.1 y	160.6 ± 8.0	5.7
Antoniazzi [25]	2000	71	Depot triptorelin, buserelin nasal spray 16–56 mo	154.4 ± 5.6	2-7
Lazar [32]	2007	115	Depot decapeptyl 2.8–4.8 y	160.35 ± 5.05	5
Pasquino [26]	2008	87	Depot triptorelin 4.2 ± 1.6 y	159.8 ± 5.3	5.1
Nabhan [27]	2009	26	Depot leuprolide 3.6 ± 2.1 y	163 ± 7.6	4.5
Magiakou [22]	2010	33	Depot triptorelin 2.75 y	158.5	6.95
Poomthavorn [21]	2011	47	Depot leuprolide or triptorelin 3.4 ± 1.5 y	158.6 ± 5.2	4.7
Bertelloni [11]	2015	25	Depot triptorelin, 3.05 ± 0.9 y	158.25 ± 5.8	3
Lee [28]	2018	84	Depot leuprolide 2.98 ± 0.73 y	160.1 ± 5	4

^aDuration data reported as mean ± SD or as a range.